Lead sponsor
Glostrup University Hospital, Copenhagen
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
2
Trials led
1
Ongoing
134
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
1
Trials by status
Recruiting
1
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.Male · Healthy volunteersnot applicableCompleted8